Regulus Therapeutics Inc. (RGLS) by event type
RGLS moves most on rating reiterations — a median of -0.33% at 30 minutes across 34 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the RGLS overview →
How RGLS reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 680 of 2,603 | 11 | +0.25% | 55% | +0.26% |
| Coverage initiations 1,104 of 2,283 | 35 | 0.00% | 54% | -0.22% |
| Rating reiterations 3,165 of 3,522 | 34 | -0.33% | 32% | +1.03% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how RGLS usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Coverage initiations → · Rating reiterations → · RGLS overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Immuron Limited - American Depositary Shares (IMRN) | 202 | -0.21% | 29% |
| InfuSystems Holdings, Inc. (INFU) | 202 | 0.00% | 50% |
| Daxor Corporation - Closed End Fund (DXR) | 200 | 0.00% | 50% |
| The Joint Corp. (JYNT) | 200 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.